Correlation Between Scpharmaceuticals and Connect Biopharma
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Connect Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Connect Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Connect Biopharma Holdings, you can compare the effects of market volatilities on Scpharmaceuticals and Connect Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Connect Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Connect Biopharma.
Diversification Opportunities for Scpharmaceuticals and Connect Biopharma
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Scpharmaceuticals and Connect is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Connect Biopharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connect Biopharma and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Connect Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connect Biopharma has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Connect Biopharma go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Connect Biopharma
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Connect Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 1.05 times less risky than Connect Biopharma. The stock trades about -0.11 of its potential returns per unit of risk. The Connect Biopharma Holdings is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 116.00 in Connect Biopharma Holdings on September 1, 2024 and sell it today you would lose (10.00) from holding Connect Biopharma Holdings or give up 8.62% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Connect Biopharma Holdings
Performance |
| Timeline |
| Scpharmaceuticals |
| Connect Biopharma |
Scpharmaceuticals and Connect Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Connect Biopharma
The main advantage of trading using opposite Scpharmaceuticals and Connect Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Connect Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connect Biopharma will offset losses from the drop in Connect Biopharma's long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Connect Biopharma vs. Assembly Biosciences | Connect Biopharma vs. Instil Bio | Connect Biopharma vs. CytomX Therapeutics | Connect Biopharma vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |